Business
Sana Biotechnology to Present Pre-Clinical Data at 2021 American Society of Hematology Annual Meeting
SEATTLE, Nov. 04, 2021 (GLOBE NEWSWIRE) -- Sana Biotechnology, Inc. (NASDAQ: SANA), a company focused on creating and delivering engineered cells as
About this update from Sana Biotechnology, Inc.
[{"type":"text","content":"SEATTLE, Nov. 04, 2021 (GLOBE NEWSWIRE) -- Sana Biotechnology, Inc. (NASDAQ: SANA), a company focused on creating and delivering engineered cells as medicines, today announced that data will be presented during four poster presentations at the 63rd American Society of Hematology (ASH) Annual Meeting and Exposition, to be held both in person in Atlanta, GA and virtually from Sunday, December 11 to Tuesday, December 14, 2021. “We are excited to share data at ASH that showcase scientific advancements from our in vivo CAR T and ex vivo allogeneic CAR T cell programs,” said Steve Harr, Sana’s President and CEO. “These presentations and publications mark the growth of our science and our continued progress toward the clinic, as we intend to file our first IND as early as next year. We celebrate our scientists as they work toward our mission of creating and delivering engineered cells as medicines for patients.” Data on the progress of several of Sana’s programs were outlined in abstracts for poster presentations, which were made available to the public online today. Information about when the full posters will be available to ASH conference participants is outlined below. Engineered hypoimmune allogeneic CAR T cells exhibit innate and adaptive immune evasion even after sensitization in humanized mice and retain potent anti-tumor activity Abstract 1690 (Poster Presentation)Session Name: 703. Cellular Immunotherapies: Basic and Translational: Poster I The session opens for viewing on Saturday, December 11, 2021, at 9:00 a.m. ET. Presentations are on Saturday, December 11, 2021, from 5:30 to 7:30 p.m. ET for in-person participants in the Georgia World Congress Center, Hall B5.Presenter: Sonja Schrepfer In addition, this abstract will be published online in the November supplemental issue of Blood, the journal of the American Society of Hematology. In vivo delivery of a CD20 CAR using a CD8-targeted fusosome in Southern pig-tail macaques (M. nemestrina) results in B cell depletion Abstract 2769 (Poster Presentation)Session Name: 703. Cellular Immunotherapies: Basic and Translational: Poster II The session opens for viewing on Sunday, December 12, 2021, at 9:00 a.m. ET. Presentations are on Sunday, December 12, 2021, from 6:00 to 8:00 p.m. ET for in-person participants in the Georgia World Congress Center, Hall B5.Presenter: Terry Fry In a...